| 000 | 01588 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513114417.0 | ||
| 264 | 0 | _c19970507 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a1073-449X | ||
| 024 | 7 |
_a10.1164/ajrccm.155.4.9105084 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGreco, M J | |
| 245 | 0 | 0 |
_aPolymer of proline analogue with sustained antifibrotic activity in lung fibrosis. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cApr 1997 |
||
| 300 |
_a1391-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBleomycin |
| 650 | 0 | 4 |
_aCollagen _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aHydroxyproline _xadministration & dosage |
| 650 | 0 | 4 | _aInstillation, Drug |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPolyethylene Glycols |
| 650 | 0 | 4 |
_aPulmonary Fibrosis _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aTrachea |
| 700 | 1 | _aKemnitzer, J E | |
| 700 | 1 | _aFox, J D | |
| 700 | 1 | _aChoe, J K | |
| 700 | 1 | _aKohn, J | |
| 700 | 1 | _aRiley, D J | |
| 700 | 1 | _aPoiani, G J | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 155 _gno. 4 _gp. 1391-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/ajrccm.155.4.9105084 _zAvailable from publisher's website |
| 999 |
_c9087166 _d9087166 |
||